FIELD: chemistry.
SUBSTANCE: invention relates to arylpiperazine derivative of formula 
its pharmaceutically acceptable salts, as well as to its deuterated form, possessing affinity with respect to D2, 5-HT1A and 5-HT2A receptors.
EFFECT: compound can be used for treatment of schizophrenia and related psychotic disorders, such as acute maniacal disorder, bipolar disorder, autistic disorder and depression.
7 cl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS, SYNTHESIS AND METHOD FOR USING ATYPICAL ANTIPSYCHOTIC DRUGS OF QUINOLINE | 2008 |
|
RU2497819C2 |
| COMPOSITIONS, SYNTHESIS AND METHODS OF USING INDANONE BASED CHOLINESTERASE INHIBITORS | 2007 |
|
RU2478619C2 |
| METHOD OF PRODUCING, METHODS OF USING AND COMPOSITION OF CYCLOALKYLMETHYLAMINES | 2007 |
|
RU2462451C2 |
| HETEROARYLIC COMPOUNDS AND METHODS FOR THEIR APPLICATION | 2013 |
|
RU2644558C2 |
| LEVODOP PRODRUGS, BASED ON THEM COMPOSITIONS AND THEIR APPLICATION | 2005 |
|
RU2365580C2 |
| PROTEIN TYROSINE KINASE RECEPTOR INHIBITOR COMPOSITIONS | 2009 |
|
RU2586212C2 |
| COMPOSITIONS, SYNTHESIS AND METHODS FOR APPLICATION OF PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES | 2012 |
|
RU2642074C2 |
| 2,4-PYRIMIDINE DIAMINE COMPOUNDS AND USE THEREOF | 2008 |
|
RU2493150C2 |
| COMPOUNDS AND METHODS FOR TREATING LEUKEMIA | 2013 |
|
RU2672553C2 |
| MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | 2011 |
|
RU2560729C2 |
